Embecta Basic EPS 2021-2025 | EMBC
Embecta basic eps from 2021 to 2025. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
| Embecta Annual Basic EPS | |
|---|---|
| 2024 | $1.36 |
| 2023 | $1.23 |
| 2022 | $3.92 |
| 2021 | $7.28 |
| 2020 | $7.50 |
| Embecta Quarterly Basic EPS | |
|---|---|
| 2025-03-31 | $0.40 |
| 2024-12-31 | $0.00 |
| 2024-09-30 | $0.26 |
| 2024-06-30 | $0.25 |
| 2024-03-31 | $0.50 |
| 2023-12-31 | $0.35 |
| 2023-09-30 | $0.10 |
| 2023-06-30 | $0.27 |
| 2023-03-31 | $0.24 |
| 2022-12-31 | $0.62 |
| 2022-09-30 | $-0.27 |
| 2022-06-30 | $1.08 |
| 2022-03-31 | $1.38 |
| 2021-12-31 | $1.73 |
| 2021-09-30 | $3.60 |
| 2021-06-30 | $1.81 |
| 2021-03-31 | $1.87 |
| 2020-12-31 | |
| 2020-09-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.580B | $1.123B |
| Embecta Corp. is a pure-play diabetes care company. Embecta is based in FRANKLIN LAKES, N.J. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $142.523B | 26.43 |
| CVS Health (CVS) | United States | $80.437B | 10.00 |
| Elevance Health (ELV) | United States | $62.242B | 8.37 |
| Cencora (COR) | United States | $56.664B | 19.71 |
| DiDi Global (DIDIY) | China | $24.380B | 25.90 |
| Labcorp Holdings (LH) | United States | $21.895B | 17.40 |
| Natera (NTRA) | United States | $19.133B | 0.00 |
| BioMerieux (BMXMF) | France | $17.067B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.105B | 0.00 |
| ICON (ICLR) | Ireland | $13.404B | 12.90 |
| CochLear (CHEOY) | Australia | $13.242B | 0.00 |
| Solventum (SOLV) | United States | $12.531B | 13.27 |
| Medpace Holdings (MEDP) | United States | $12.257B | 32.44 |
| Viatris (VTRS) | United States | $10.540B | 3.62 |
| Revvity (RVTY) | United States | $10.453B | 18.14 |
| Sonic Healthcare (SKHHY) | Australia | $8.877B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.226B | 16.12 |
| Avantor (AVTR) | United States | $7.935B | 11.64 |
| HealthEquity (HQY) | United States | $7.870B | 34.47 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.708B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $5.109B | 34.38 |
| Amplifon S.p.A (AMFPF) | Italy | $3.890B | 21.30 |
| BrightSpring Health Services (BTSG) | United States | $3.516B | 26.82 |
| Sotera Health (SHC) | United States | $3.176B | 18.05 |
| GeneDx Holdings (WGS) | United States | $3.043B | 70.16 |
| Surgery Partners (SGRY) | United States | $2.837B | 35.71 |
| Alignment Healthcare (ALHC) | United States | $2.656B | 0.00 |
| Concentras Parent (CON) | United States | $2.540B | 14.68 |
| Organon (OGN) | United States | $2.184B | 2.38 |
| Progyny (PGNY) | United States | $1.990B | 43.81 |
| Premier (PINC) | United States | $1.788B | 13.57 |
| PACS (PACS) | United States | $1.740B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.568B | 31.36 |
| Ardent Health (ARDT) | United States | $1.523B | 5.88 |
| Establishment Labs Holdings (ESTA) | $1.273B | 0.00 | |
| Teladoc Health (TDOC) | United States | $1.230B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.110B | 7.51 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.831B | 285.00 |
| CareDx (CDNA) | United States | $0.715B | 11.17 |
| AMN Healthcare Services Inc (AMN) | United States | $0.670B | 6.27 |
| Performant Healthcare (PHLT) | United States | $0.597B | 0.00 |
| LifeMD (LFMD) | United States | $0.538B | 0.00 |
| Nutex Health (NUTX) | United States | $0.506B | 7.67 |
| So-Young (SY) | China | $0.499B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.466B | 10.50 |
| InnovAge Holding (INNV) | United States | $0.466B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.457B | 0.00 |
| SBC Medicals (SBC) | United States | $0.453B | 0.00 |
| Omada Health (OMDA) | $0.446B | 0.00 | |
| COMPASS Pathways (CMPS) | United Kingdom | $0.430B | 0.00 |
| Agilon Health (AGL) | United States | $0.365B | 0.00 |
| Oncology Institute (TOI) | United States | $0.353B | 0.00 |
| Enhabit (EHAB) | United States | $0.339B | 27.88 |
| Beauty Health (SKIN) | United States | $0.208B | 0.00 |
| DocGo (DCGO) | United States | $0.143B | 23.33 |
| Ascend Wellness Holdings (AAWH) | United States | $0.094B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.092B | 0.00 |
| Biodesix (BDSX) | United States | $0.062B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| KindlyMD (NAKA) | United States | $0.053B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.052B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.040B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.038B | 0.00 |
| ModivCare (MODV) | United States | $0.037B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.014B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.007B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |